Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045
- PMID: 20168204
- PMCID: PMC3154736
- DOI: 10.1097/QAD.0b013e328336095d
Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045
Abstract
Objective: To characterize total body bone mineral content (BMC) and total body and spinal bone mineral density (BMD) in perinatally HIV-infected and uninfected children/youth across puberty.
Design: HIV-infected (7-24 years) were randomly selected from six strata based on Tanner stage/protease inhibitor use. HIV-uninfected were frequency-matched by Tanner group and sociodemographic background to the HIV-infected.
Methods: Dual-energy X-ray absorptiometry (DXA) measured BMC and BMD. Linear regression models tested differences in bone outcomes by HIV and the interaction of HIV by Tanner group (1-2, 3-4, 5). Models were performed separately by sex and adjusted for DXA scanner, race/ethnicity, height, age and lean body mass.
Results: HIV-infected (N = 236) and uninfected (N = 143) were comparable on sex and race/ethnicity. HIV-infected were slightly older (median 12.6 versus 11.9 years). In adjusted models, HIV-infected males had significantly lower total body BMC and total body and spinal BMD at Tanner 5, lower BMC at Tanner 3-4 and similar BMC and BMD at Tanner 1-2, compared to HIV-uninfected males. HIV-infected and uninfected girls did not differ significantly on any bone outcome, but there was a marginally significant interaction of HIV and Tanner group for spinal BMD. Kaletra/ritonavir was associated with lower BMC and total body BMD and nevirapine was associated with higher spinal BMD in a model with all HIV-infected.
Conclusions: Perinatally HIV-infected males showed more evidence of lower bone density especially in the final stage of pubertal development than HIV-infected girls and they may be at increased risk for bone disease during adulthood.
Figures
Similar articles
-
Bone Accrual Trajectories in Children and Adolescents With Perinatal HIV Infection.J Clin Endocrinol Metab. 2025 May 19;110(6):e1783-e1792. doi: 10.1210/clinem/dgae631. J Clin Endocrinol Metab. 2025. PMID: 39312415
-
Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy X-ray absorptiometry measurements.Osteoporos Int. 2005 Nov;16(11):1393-6. doi: 10.1007/s00198-005-1849-9. Epub 2005 Feb 9. Osteoporos Int. 2005. PMID: 15702261
-
Predictors of bone mineral density in human immunodeficiency virus-1 infected children.J Pediatr Gastroenterol Nutr. 2005 Sep;41(3):339-46. doi: 10.1097/01.mpg.0000174468.75219.30. J Pediatr Gastroenterol Nutr. 2005. PMID: 16131991
-
Older age at initiation of antiretroviral therapy predicts low bone mineral density in children with perinatally-infected HIV in Zimbabwe.Bone. 2019 Aug;125:96-102. doi: 10.1016/j.bone.2019.05.012. Epub 2019 May 10. Bone. 2019. PMID: 31082498 Free PMC article.
-
Differences in bone mineral in young Asian and Caucasian Americans may reflect differences in bone size.J Bone Miner Res. 1996 Oct;11(10):1545-56. doi: 10.1002/jbmr.5650111023. J Bone Miner Res. 1996. PMID: 8889856
Cited by
-
The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV.J Int AIDS Soc. 2020 Sep;23 Suppl 5(Suppl 5):e25576. doi: 10.1002/jia2.25576. J Int AIDS Soc. 2020. PMID: 32869500 Free PMC article.
-
Incident fractures in HIV-infected individuals: a systematic review and meta-analysis.AIDS. 2013 Jul 31;27(12):1949-57. doi: 10.1097/QAD.0b013e328361d241. AIDS. 2013. PMID: 24126140 Free PMC article.
-
Immune Markers and Their Association with Bone Density in Children, Adolescents, and Young Adults with Perinatally Acquired HIV.AIDS Res Hum Retroviruses. 2021 Feb;37(2):122-129. doi: 10.1089/AID.2020.0171. Epub 2020 Nov 11. AIDS Res Hum Retroviruses. 2021. PMID: 33066711 Free PMC article.
-
The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents.J Int AIDS Soc. 2013 Jun 18;16(1):18555. doi: 10.7448/IAS.16.1.18555. J Int AIDS Soc. 2013. PMID: 23782474 Free PMC article. Review.
-
Bone health in children and adolescents with perinatal HIV infection.J Int AIDS Soc. 2013 Jun 18;16(1):18575. doi: 10.7448/IAS.16.1.18575. J Int AIDS Soc. 2013. PMID: 23782476 Free PMC article. Review.
References
-
- Arpadi SM, Horlick M, Thornton J, Cuff PA, Wang J, Kotler DP. Bone mineral content is lower in prepubertal HIV-infected children. J Acquir Immune Defic Syndr. 2002;29:450–454. - PubMed
-
- O'Brien KO, Razavi M, Henderson RA, Caballero B, Ellis KJ. Bone mineral content in girls perinatally infected with HIV. Am J Clin Nutr. 2001;73:821–826. - PubMed
-
- Mora S, Zamproni I, Beccio S, Bianchi R, Giacomet V, Vigano A. Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children. J Clin Endocrinol Metab. 2004;89:24–28. - PubMed
-
- Jacobson DL, Spiegelman D, Duggan C, Weinberg GA, Bechard L, Furuta L, et al. Predictors of bone mineral density in human immunodeficiency virus-1 infected children. J Pediatr Gastroenterol Nutr. 2005;41:339–346. - PubMed
-
- Amorosa V, Tebas P. Bone disease and HIV infection. Clin Infect Dis. 2006;42:108–114. - PubMed
Publication types
MeSH terms
Grants and funding
- 5U01A1068616/PHS HHS/United States
- 1 U01 AI068632-01/AI/NIAID NIH HHS/United States
- P30 DK040561/DK/NIDDK NIH HHS/United States
- HHSN267200800001G/DK/NIDDK NIH HHS/United States
- UM1 AI068632/AI/NIAID NIH HHS/United States
- M01 RR001271/RR/NCRR NIH HHS/United States
- U01 AI068616/AI/NIAID NIH HHS/United States
- HHSN267200800001C/HD/NICHD NIH HHS/United States
- U01 AI041110/AI/NIAID NIH HHS/United States
- N01-DK-9-001/HHSN267200800001C/DK/NIDDK NIH HHS/United States
- AI068632/AI/NIAID NIH HHS/United States
- M01 RR000069/RR/NCRR NIH HHS/United States
- U01 AI068632/AI/NIAID NIH HHS/United States
- #1 U01 AI068616/AI/NIAID NIH HHS/United States
- #5 U01 AI41110/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical